Lapatinib Resistance in Patients With Breast Cancer

Withdrawn before enrolling

Conditions studied: Breast Cancer

In brief

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance in patients. PURPOSE: This research study is looking at lapatinib resistance in patients with breast cancer.

Key facts

Study ID

NCT00898573

Run by

Case Comprehensive Cancer Center

People needed

0

Starts

2008-07-01

Last updated by the study team

2015-10-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Geauga Regional Hospital — Cleveland, Ohio, United States
• Lake/University Ireland Cancer Center — Cleveland, Ohio, United States
• Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• University Suburban Health Center — Cleveland, Ohio, United States
• UHHS Chagrin Highlands Medical Center — Cleveland, Ohio, United States
• Southwest General Health Center — Cleveland, Ohio, United States
• UHHS Westlake Medical Center — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• Mercy Cancer Center at Mercy Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.